RCS - Borussia Dortmund - Berenberg initiates research coverage of BVB share

Borussia Dortmund GmbH & Co KgaAAnnouncement

09/03/2020 11:15

RNS Number : 4286F
  

Borussia Dortmund GmbH & Co. KGaA
  
09 March 2020
  
 




Borussia Dortmund GmbH & Co. KGaA / Key word(s): Research Update

Berenberg initiates research coverage of BVB share with a 'buy' recommendation and a target share price of 12.00 EUR



09.03.2020

The issuer is solely responsible for the content of this announcement.
 
Joh. Berenberg, Gossler & Co. KG ("Berenberg"), Hamburg, initiates research coverage of BVB share according to its initial research study dated March 6th, 2020 with a "buy recommendation and a target price of 12.00 EUR.
For further information please see the column "capital markets view" under www.bvb.de/aktie.
Dortmund, March 9th, 2020
Borussia Dortmund GmbH & Co. KGaA

Borussia Dortmund Geschäftsführungs-GmbH


Contact:

Dr. Robin Steden

Inhouse Counsel / Investor Relations
 
 
09.03.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.



The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
 







Language:


English




Company:


Borussia Dortmund GmbH & Co. KGaA








Rheinlanddamm 207 - 209








44137 Dortmund








Germany




Phone:


0231/ 90 20 - 2746




Fax:


0231/ 90 20 - 852746




E-mail:


aktie@bvb.de




Internet:


www.bvb.de/aktie // www.aktie.bvb.de




ISIN:


DE0005493092




WKN:


549309




Indices:


SDAX




Listed:


Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange




EQS News ID:


992423



 











End of News


DGAP News Service





992423  09.03.2020 
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
NRAUPUBUWUPUGUB